362 related articles for article (PubMed ID: 11507057)
1. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model.
Zhao Y; Xue Y; Oberley TD; Kiningham KK; Lin SM; Yen HC; Majima H; Hines J; St Clair D
Cancer Res; 2001 Aug; 61(16):6082-8. PubMed ID: 11507057
[TBL] [Abstract][Full Text] [Related]
2. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling.
Shrotriya S; Kundu JK; Na HK; Surh YJ
Cancer Res; 2010 Mar; 70(5):1932-40. PubMed ID: 20179211
[TBL] [Abstract][Full Text] [Related]
3. Organ-specific activation of activator protein-1 in transgenic mice by 12-o-tetradecanoylphorbol-13-acetate with different administration methods.
Zhong S; Quealy JA; Bode AM; Nomura M; Kaji A; Ma WY; Dong Z
Cancer Res; 2001 May; 61(10):4084-91. PubMed ID: 11358830
[TBL] [Abstract][Full Text] [Related]
4. Manganese superoxide dismutase deficiency enhances cell turnover via tumor promoter-induced alterations in AP-1 and p53-mediated pathways in a skin cancer model.
Zhao Y; Oberley TD; Chaiswing L; Lin SM; Epstein CJ; Huang TT; St Clair D
Oncogene; 2002 May; 21(24):3836-46. PubMed ID: 12032821
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
Chun KS; Kim SH; Song YS; Surh YJ
Carcinogenesis; 2004 May; 25(5):713-22. PubMed ID: 14729583
[TBL] [Abstract][Full Text] [Related]
6. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase.
Lu YP; Lou YR; Yen P; Newmark HL; Mirochnitchenko OI; Inouye M; Huang MT
Cancer Res; 1997 Apr; 57(8):1468-74. PubMed ID: 9108447
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
8. A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion.
Thompson EJ; MacGowan J; Young MR; Colburn N; Bowden GT
Cancer Res; 2002 Jun; 62(11):3044-7. PubMed ID: 12036911
[TBL] [Abstract][Full Text] [Related]
9. In situ reduction of oxidative damage, increased cell turnover, and delay of mitochondrial injury by overexpression of manganese superoxide dismutase in a multistage skin carcinogenesis model.
Oberley TD; Xue Y; Zhao Y; Kiningham K; Szweda LI; St Clair DK
Antioxid Redox Signal; 2004 Jun; 6(3):537-48. PubMed ID: 15130280
[TBL] [Abstract][Full Text] [Related]
10. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
11. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.
Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA
Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.
Reddig PJ; Dreckschmidt NE; Ahrens H; Simsiman R; Tseng CP; Zou J; Oberley TD; Verma AK
Cancer Res; 1999 Nov; 59(22):5710-8. PubMed ID: 10582689
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of manganese superoxide dismutase selectively modulates the activity of Jun-associated transcription factors in fibrosarcoma cells.
Kiningham KK; St Clair DK
Cancer Res; 1997 Dec; 57(23):5265-71. PubMed ID: 9393747
[TBL] [Abstract][Full Text] [Related]
14. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress.
Krysan K; Lou MF
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
16. Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin.
Garg R; Ramchandani AG; Maru GB
Carcinogenesis; 2008 Jun; 29(6):1249-57. PubMed ID: 18477648
[TBL] [Abstract][Full Text] [Related]
17. Dietary energy restriction, in part through glucocorticoid hormones, mediates the impact of 12-O-tetradecanoylphorbol-13-acetate on jun D and fra-1 in Sencar mouse epidermis.
Przybyszewski J; Wang W; Au A; Perry C; Guetzko M; Koehler K; Birt DF
Mol Carcinog; 2010 Jun; 49(6):592-602. PubMed ID: 20232358
[TBL] [Abstract][Full Text] [Related]
18. High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.
Zoumpourlis V; Papassava P; Linardopoulos S; Gillespie D; Balmain A; Pintzas A
Oncogene; 2000 Aug; 19(35):4011-21. PubMed ID: 10962557
[TBL] [Abstract][Full Text] [Related]
19. Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK
Cancer Res; 2000 Feb; 60(3):595-602. PubMed ID: 10676642
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
